Left ventricular plasty improved cardiac function in a case of takotsubo cardiomyopathy with persistent aneurysm

Makiko Miyata1, Kazuhiko Nakazato1, Nobuo Sakamoto1

  • 1Department of Cardiology and Hematology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.

Journal of Cardiology Cases
|December 12, 2018
PubMed

Insights

Takotsubo cardiomyopathy typically resolves favorably, but this case involved persistent heart failure. Surgical left ventricular (LV) plasty successfully improved LV function and symptoms in a patient with a LV aneurysm.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery

Background:

  • Takotsubo cardiomyopathy (TTC) usually has a good prognosis with spontaneous recovery of left ventricular (LV) function.
  • Persistent LV dysfunction and heart failure are rare complications of TTC.

Purpose of the Study:

  • To report a rare case of TTC with a LV aneurysm and persistent heart failure.
  • To highlight the successful surgical intervention for severe LV dysfunction in TTC.

Main Methods:

  • Diagnosis of TTC based on clinical presentation, ECG, echocardiography, and cardiac catheterization.
  • Medical management with beta-blockers, aldosterone receptor blockers, and ACE inhibitors.
  • Surgical LV plasty (aneurysm resection and LV volume reduction) for refractory heart failure.

Main Results:

  • The patient presented with chest pain, elevated cardiac enzymes, and ECG changes consistent with myocardial infarction, but angiography revealed no significant coronary stenosis.
  • Echocardiography showed apical ballooning and basal hyperkinesis, indicative of TTC, but LV function did not improve with medical therapy.
  • Surgical LV plasty resulted in dramatic improvement in LV systolic function and clinical symptoms, with pathological findings of fibrosis and adipose tissue in the resected LV aneurysm.

Conclusions:

  • Surgical LV plasty can be a viable option for managing rare cases of TTC with persistent severe heart failure and LV aneurysm.
  • Pathological examination revealed myocardial damage and replacement fibrosis within the LV aneurysm, explaining the persistent dysfunction.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
566
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
708
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
488
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
605